← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2019-05-01

Drug application

FDA Application #
ANDA090198
Application type
Abbreviated New Drug Application (Generic)
Brand name
LAMIVUDINE
Generic name
LAMIVUDINE
Active ingredients
LAMIVUDINE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
MACLEODS PHARMS LTD
Manufacturer
Macleods Pharmaceuticals Limited
First approval
2019-05-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown